{"entity":{"type":"insider","cik":"0001277495","url":"/insider/0001277495","json_url":"/insider/0001277495.json","name":"BOESS CARSTEN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":120,"n_filings":26,"first":"2005-06-29","last":"2015-02-19","span_basis":"filed_date"},"name_variants":[{"name":"BOESS CARSTEN","source":"filing","n_filings":26,"first_seen":"2005-06-29","last_seen":"2015-02-19"}],"transactions":[{"id":8830197,"accession":"0001246360-15-000989","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001246360-15-000989","line_url":"/filing/0001246360-15-000989","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42297.0,"shares_display":"42,297","price_per_share":100.11118920963662,"price_display":"100.11","price_state":"stated","total_value":4234402.97,"total_display":"4,234,402.97","total_whole":"4,234,403","shares_owned_after":1842.0,"shares_owned_after_display":"1,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-19","scope":"insider","n_lines":4},{"id":6505813,"accession":"0001246360-14-004229","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001246360-14-004229","line_url":"/filing/0001246360-14-004229#line-7","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22904.0,"shares_display":"22,904","price_per_share":80.11,"price_display":"80.11","price_state":"stated","total_value":1834839.44,"total_display":"1,834,839.44","total_whole":"1,834,839","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-30","filed_date":"2014-10-30","scope":"insider"},{"id":6505806,"accession":"0001246360-14-004229","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001246360-14-004229","line_url":"/filing/0001246360-14-004229","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-28","filed_date":"2014-10-30","scope":"insider","n_lines":2},{"id":6381203,"accession":"0001246360-14-002604","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001246360-14-002604","line_url":"/filing/0001246360-14-002604","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9927.0,"shares_display":"9,927","price_per_share":81.93831066787548,"price_display":"81.94","price_state":"stated","total_value":813401.61,"total_display":"813,401.61","total_whole":"813,402","shares_owned_after":1791.0,"shares_owned_after_display":"1,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-16","filed_date":"2014-05-20","scope":"insider","n_lines":3},{"id":6505493,"accession":"0001246360-14-001257","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001246360-14-001257","line_url":"/filing/0001246360-14-001257","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9927.0,"shares_display":"9,927","price_per_share":101.98131661126222,"price_display":"101.98","price_state":"stated","total_value":1012368.53,"total_display":"1,012,368.53","total_whole":"1,012,369","shares_owned_after":2639.0,"shares_owned_after_display":"2,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider","n_lines":5},{"id":5400609,"accession":"0001246360-13-005065","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001246360-13-005065","line_url":"/filing/0001246360-13-005065","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9927.0,"shares_display":"9,927","price_per_share":55.08782310869346,"price_display":"55.09","price_state":"stated","total_value":546856.82,"total_display":"546,856.82","total_whole":"546,857","shares_owned_after":6066.0,"shares_owned_after_display":"6,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-20","scope":"insider","n_lines":4},{"id":5203148,"accession":"0001246360-13-004106","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001246360-13-004106","line_url":"/filing/0001246360-13-004106#line-5","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6681.0,"shares_display":"6,681","price_per_share":47.19,"price_display":"47.19","price_state":"stated","total_value":315276.39,"total_display":"315,276.39","total_whole":"315,276","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-21","filed_date":"2013-08-22","scope":"insider"},{"id":5203140,"accession":"0001246360-13-004106","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001246360-13-004106","line_url":"/filing/0001246360-13-004106#line-3","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7800.0,"shares_display":"7,800","price_per_share":47.04,"price_display":"47.04","price_state":"stated","total_value":366912.0,"total_display":"366,912.00","total_whole":"366,912","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-20","filed_date":"2013-08-22","scope":"insider"},{"id":4740227,"accession":"0001246360-13-004087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001246360-13-004087","line_url":"/filing/0001246360-13-004087#line-2","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":47.47,"price_display":"47.47","price_state":"stated","total_value":204121.0,"total_display":"204,121.00","total_whole":"204,121","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-16","filed_date":"2013-08-20","scope":"insider"},{"id":4797263,"accession":"0001246360-13-003588","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001246360-13-003588","line_url":"/filing/0001246360-13-003588#line-2","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13237.0,"shares_display":"13,237","price_per_share":47.06,"price_display":"47.06","price_state":"stated","total_value":622933.22,"total_display":"622,933.22","total_whole":"622,933","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-11","filed_date":"2013-07-15","scope":"insider"},{"id":5174746,"accession":"0001246360-13-000515","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001246360-13-000515","line_url":"/filing/0001246360-13-000515#line-2","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9927.0,"shares_display":"9,927","price_per_share":49.12,"price_display":"49.12","price_state":"stated","total_value":487614.24,"total_display":"487,614.24","total_whole":"487,614","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-16","filed_date":"2013-01-18","scope":"insider"},{"id":3443566,"accession":"0001246360-12-004159","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001246360-12-004159","line_url":"/filing/0001246360-12-004159","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9927.0,"shares_display":"9,927","price_per_share":50.130931802155736,"price_display":"50.13","price_state":"stated","total_value":497649.76,"total_display":"497,649.76","total_whole":"497,650","shares_owned_after":2800.0,"shares_owned_after_display":"2,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-16","filed_date":"2012-10-18","scope":"insider","n_lines":3},{"id":3028612,"accession":"0001246360-12-003148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001246360-12-003148","line_url":"/filing/0001246360-12-003148#line-2","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6618.0,"shares_display":"6,618","price_per_share":48.82,"price_display":"48.82","price_state":"stated","total_value":323090.76,"total_display":"323,090.76","total_whole":"323,091","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-18","filed_date":"2012-07-20","scope":"insider"},{"id":3547012,"accession":"0001246360-12-002483","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001246360-12-002483","line_url":"/filing/0001246360-12-002483","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39709.0,"shares_display":"39,709","price_per_share":38.35233725351935,"price_display":"38.35","price_state":"stated","total_value":1522932.96,"total_display":"1,522,932.96","total_whole":"1,522,933","shares_owned_after":11572.0,"shares_owned_after_display":"11,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-16","filed_date":"2012-05-18","scope":"insider","n_lines":2},{"id":9031633,"accession":"0001127602-11-013840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-013840","line_url":"/filing/0001127602-11-013840#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Vice President, International)","role_mark":"O","role_mark_label":"Officer (Vice President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41296.0,"shares_display":"41,296","price_per_share":21.5445,"price_display":"21.54","price_state":"stated","total_value":889701.672,"total_display":"889,701.67","total_whole":"889,702","shares_owned_after":18941.0,"shares_owned_after_display":"18,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-25","filed_date":"2011-04-27","scope":"insider"},{"id":9031620,"accession":"0001127602-11-013352","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-013352","line_url":"/filing/0001127602-11-013352#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Vice President, International)","role_mark":"O","role_mark_label":"Officer (Vice President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":21.5,"price_display":"21.50","price_state":"stated","total_value":129000.0,"total_display":"129,000.00","total_whole":"129,000","shares_owned_after":18941.0,"shares_owned_after_display":"18,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-18","filed_date":"2011-04-20","scope":"insider"},{"id":9050815,"accession":"0001127602-11-011487","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-11-011487","line_url":"/filing/0001127602-11-011487#line-4","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Vice President, International)","role_mark":"O","role_mark_label":"Officer (Vice President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11900.0,"shares_display":"11,900","price_per_share":20.6677,"price_display":"20.67","price_state":"stated","total_value":245945.63,"total_display":"245,945.63","total_whole":"245,946","shares_owned_after":18941.0,"shares_owned_after_display":"18,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-30","filed_date":"2011-03-31","scope":"insider"},{"id":9050813,"accession":"0001127602-11-011487","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-011487","line_url":"/filing/0001127602-11-011487#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Vice President, International)","role_mark":"O","role_mark_label":"Officer (Vice President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35396.0,"shares_display":"35,396","price_per_share":20.5228,"price_display":"20.52","price_state":"stated","total_value":726425.0288,"total_display":"726,425.03","total_whole":"726,425","shares_owned_after":18941.0,"shares_owned_after_display":"18,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-29","filed_date":"2011-03-31","scope":"insider"},{"id":9138389,"accession":"0001127602-11-011222","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-11-011222","line_url":"/filing/0001127602-11-011222#line-4","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Vice President, International)","role_mark":"O","role_mark_label":"Officer (Vice President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15900.0,"shares_display":"15,900","price_per_share":19.7645,"price_display":"19.76","price_state":"stated","total_value":314255.55,"total_display":"314,255.55","total_whole":"314,256","shares_owned_after":18941.0,"shares_owned_after_display":"18,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-25","filed_date":"2011-03-25","scope":"insider"},{"id":9138387,"accession":"0001127602-11-011222","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-011222","line_url":"/filing/0001127602-11-011222#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Vice President, International)","role_mark":"O","role_mark_label":"Officer (Vice President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31396.0,"shares_display":"31,396","price_per_share":19.5064,"price_display":"19.51","price_state":"stated","total_value":612422.9344,"total_display":"612,422.93","total_whole":"612,423","shares_owned_after":18941.0,"shares_owned_after_display":"18,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-24","filed_date":"2011-03-25","scope":"insider"},{"id":8879776,"accession":"0001127602-11-004652","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-004652","line_url":"/filing/0001127602-11-004652#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Vice President, International)","role_mark":"O","role_mark_label":"Officer (Vice President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5056.0,"shares_display":"5,056","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":88480.0,"total_display":"88,480.00","total_whole":"88,480","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-07","filed_date":"2011-02-09","scope":"insider"},{"id":9167299,"accession":"0001127602-11-003912","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-11-003912","line_url":"/filing/0001127602-11-003912#line-3","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Vice President, International)","role_mark":"O","role_mark_label":"Officer (Vice President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31813.0,"shares_display":"31,813","price_per_share":17.5064,"price_display":"17.51","price_state":"stated","total_value":556931.1032,"total_display":"556,931.10","total_whole":"556,931","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-02","filed_date":"2011-02-04","scope":"insider"},{"id":8993525,"accession":"0001127602-11-001960","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-001960","line_url":"/filing/0001127602-11-001960#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Vice President, International)","role_mark":"O","role_mark_label":"Officer (Vice President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10428.0,"shares_display":"10,428","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":182490.0,"total_display":"182,490.00","total_whole":"182,490","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-18","filed_date":"2011-01-20","scope":"insider"},{"id":7297814,"accession":"0001127602-10-025180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-10-025180","line_url":"/filing/0001127602-10-025180#line-1","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Vice President, International)","role_mark":"O","role_mark_label":"Officer (Vice President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23240.0,"shares_display":"23,240","price_per_share":15.026,"price_display":"15.03","price_state":"stated","total_value":349204.24,"total_display":"349,204.24","total_whole":"349,204","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-05","filed_date":"2010-10-07","scope":"insider"},{"id":3894723,"accession":"0001209191-08-060422","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-060422","line_url":"/filing/0001209191-08-060422#line-1","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23240.0,"shares_display":"23,240","price_per_share":5.07,"price_display":"5.07","price_state":"stated","total_value":117826.8,"total_display":"117,826.80","total_whole":"117,827","shares_owned_after":23240.0,"shares_owned_after_display":"23,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-11","filed_date":"2008-11-13","scope":"insider"},{"id":7705606,"accession":"0001209191-07-067953","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-07-067953","line_url":"/filing/0001209191-07-067953#line-17","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7153.0,"shares_display":"7,153","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":178825.0,"total_display":"178,825.00","total_whole":"178,825","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-05","filed_date":"2007-12-05","scope":"insider"},{"id":7705601,"accession":"0001209191-07-067953","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-07-067953","line_url":"/filing/0001209191-07-067953#line-15","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":55000.0,"total_display":"55,000.00","total_whole":"55,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-04","filed_date":"2007-12-05","scope":"insider"},{"id":7705596,"accession":"0001209191-07-067953","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-07-067953","line_url":"/filing/0001209191-07-067953#line-13","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":23.6,"price_display":"23.60","price_state":"stated","total_value":56640.0,"total_display":"56,640.00","total_whole":"56,640","shares_owned_after":5710.0,"shares_owned_after_display":"5,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-03","filed_date":"2007-12-05","scope":"insider"},{"id":7705593,"accession":"0001209191-07-067953","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-07-067953","line_url":"/filing/0001209191-07-067953#line-12","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":23.5,"price_display":"23.50","price_state":"stated","total_value":47000.0,"total_display":"47,000.00","total_whole":"47,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-03","filed_date":"2007-12-05","scope":"insider"},{"id":7705591,"accession":"0001209191-07-067953","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-07-067953","line_url":"/filing/0001209191-07-067953#line-11","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":760.0,"shares_display":"760","price_per_share":23.51,"price_display":"23.51","price_state":"stated","total_value":17867.6,"total_display":"17,867.60","total_whole":"17,868","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-03","filed_date":"2007-12-05","scope":"insider"},{"id":7705588,"accession":"0001209191-07-067953","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-07-067953","line_url":"/filing/0001209191-07-067953#line-10","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":23.57,"price_display":"23.57","price_state":"stated","total_value":14142.0,"total_display":"14,142.00","total_whole":"14,142","shares_owned_after":4110.0,"shares_owned_after_display":"4,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-03","filed_date":"2007-12-05","scope":"insider"},{"id":7705586,"accession":"0001209191-07-067953","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-07-067953","line_url":"/filing/0001209191-07-067953#line-9","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":23.61,"price_display":"23.61","price_state":"stated","total_value":11805.0,"total_display":"11,805.00","total_whole":"11,805","shares_owned_after":8110.0,"shares_owned_after_display":"8,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-03","filed_date":"2007-12-05","scope":"insider"},{"id":7705583,"accession":"0001209191-07-067953","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-07-067953","line_url":"/filing/0001209191-07-067953#line-8","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":23.59,"price_display":"23.59","price_state":"stated","total_value":11795.0,"total_display":"11,795.00","total_whole":"11,795","shares_owned_after":5210.0,"shares_owned_after_display":"5,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-03","filed_date":"2007-12-05","scope":"insider"},{"id":7705580,"accession":"0001209191-07-067953","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-07-067953","line_url":"/filing/0001209191-07-067953#line-7","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001277495","owner_name":"BOESS CARSTEN","owner_display_name":"BOESS CARSTEN","owner_url":"/insider/0001277495","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":23.58,"price_display":"23.58","price_state":"stated","total_value":11790.0,"total_display":"11,790.00","total_whole":"11,790","shares_owned_after":4710.0,"shares_owned_after_display":"4,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-03","filed_date":"2007-12-05","scope":"insider"}],"collapsed":true,"next_cursor":"2007-12-03|7705580","ledger_fault":false,"count":{"value":120,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":119,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":120},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000911326","name":"SYNAGEVA BIOPHARMA CORP","url":"/issuer/0000911326","role":"Officer (SVP, Chief Financial Officer)","n_filings":12,"first_seen":"2012-05-18","last_seen":"2015-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001145197","name":"INSULET CORP","url":"/issuer/0001145197","role":"Officer (Vice President, International)","n_filings":12,"first_seen":"2007-12-05","last_seen":"2011-04-27"},{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Other","n_filings":2,"first_seen":"2005-06-29","last_seen":"2005-06-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001277495","retrieved_at":"2026-08-26T04:49:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}